Successful lymphoablative autologous haematopoietic stem cell transplantation in three cases of severe autoimmune disease despite reduced dose cyclophosphamide conditioning-do we need 200 mg/kg cyclophosphamide?

Bone Marrow Transplant. 2022 Jul;57(7):1207-1209. doi: 10.1038/s41409-022-01696-5. Epub 2022 May 6.

Ross Penglase^{1

2

3}, Helen Englert⁴, Kathleen Tymms^{5

6}, Andrew Carr⁷, David Ma^{8

9

4}, Sam Milliken⁴, John Moore^{8

9

4}

¹ Rheumatology Department, St Vincent's Hospital, Sydney, NSW, Australia. ross.penglase@svha.org.au.
² St Vincent's Centre for Applied Medical Research, Sydney, NSW, Australia. ross.penglase@svha.org.au.
³ University of New South Wales, Medical School, Sydney, NSW, Australia. ross.penglase@svha.org.au.
⁴ Haematology Department, St Vincent's Hospital, Sydney, NSW, Australia.
⁵ Canberra Rheumatology, Canberra, ACT, Australia.
⁶ Rheumatology Department, Canberra Hospital, Canberra, ACT, Australia.
⁷ Immunology Department, St Vincent's Hospital, Sydney, NSW, Australia.
⁸ St Vincent's Centre for Applied Medical Research, Sydney, NSW, Australia.
⁹ University of New South Wales, Medical School, Sydney, NSW, Australia.

No abstract available

Publication types